TAK-418

CAS No. 1818252-53-7

TAK-418( —— )

Catalog No. M35103 CAS No. 1818252-53-7

TAK-418 is a selective and orally active inhibitor of LSD1/KDM1A enzyme with an IC50 of 2.9 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 387 In Stock
5MG 330 In Stock
10MG 521 In Stock
25MG 1064 In Stock
50MG 1404 In Stock
100MG 1879 In Stock
200MG 2539 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TAK-418
  • Note
    Research use only, not for human use.
  • Brief Description
    TAK-418 is a selective and orally active inhibitor of LSD1/KDM1A enzyme with an IC50 of 2.9 nM.
  • Description
    TAK-418 is a selective, orally active LSD1 (KDM1A) enzyme inhibitor with an IC50 of 2.9 nM. TAK-418 unlocks aberrant epigenetic machinery and improves autism symptoms in neurodevelopmental disorder models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    Histone Demethylase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1818252-53-7
  • Formula Weight
    356.91
  • Molecular Formula
    C17H25ClN2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 55 mg/mL (154.10 mM; Ultrasonic (<60°C); )H2O : ≥ 16.67 mg/mL (46.71 mM)
  • SMILES
    Cl.O=C(NC1CCOCC1)c1csc(c1)[C@@H]1C[C@H]1NCC1CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Baba R, et al. LSD1 enzyme inhibitor TAK-418 unlocks aberrant epigenetic machinery and improves autism symptoms in neurodevelopmental disorder models. Sci Adv. 2021;7(11):eaba1187. Published 2021 Mar 12.?
molnova catalog
related products
  • KDM2B-IN-2

    KDM2B-IN-2 is a potent histone demethylase (kdm2b) inhibitor.

  • PF-06821497

    PF-06821497 is a selective inhibitor of EZH2 with significant tumor growth inhibition.

  • EZM0414

    EZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.